Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3016% below fair value
$9.15−0.02 (-0.22%)
Close on Nov 16, 2026Market cap $348.51MP/E 25.4Yield –
Viemed Healthcare price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Viemed Healthcare's price to sales ratio was 1.2× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 1.0× to 3.0×, with a median of 1.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | +0.0 |
| 2025 | Dec 31, 2025 | 1.1× | −0.3 |
| 2024 | Dec 31, 2024 | 1.5× | −0.3 |
| 2023 | Dec 29, 2023 | 1.8× | −0.4 |
| 2022 | Dec 30, 2022 | 2.2× | +0.4 |
| 2021 | Dec 31, 2021 | 1.8× | −0.7 |
| 2020 | Dec 31, 2020 | 2.5× | −0.6 |
| 2019 | Dec 31, 2019 | 3.0× | – |
See a number that looks wrong?